Synlogic, Inc. (SYBX) — 10-Q Filings
All 10-Q filings from Synlogic, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Synlogic's Net Loss Widens Amid Restructuring, Cash Holds Steady
— Nov 13, 2025 Risk: high
SYNLOGIC, INC. (SYBX) reported a significant increase in net loss for the three months ended September 30, 2025, reaching $2.301 million, compared to a net loss -
Synlogic's Q2 Loss Widens Amid Rising G&A, R&D Declines
— Aug 7, 2025 Risk: high
SYNLOGIC, INC. reported a net loss of $17.3 million for the three months ended June 30, 2025, a significant increase from the $12.1 million net loss in the prio -
Synlogic, Inc. Q1 2025 10-Q Filing
— May 8, 2025 Risk: medium
Synlogic, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial activities including preferred stock, pre-funded warrants, and -
Synlogic, Inc. Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Synlogic, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Mirna Therapeutics, Inc., is in the pharmaceutical prepar -
Synlogic, Inc. Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk: medium
SYNLOGIC, INC. (SYBX) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Synlogic, Inc. filed a 10-Q report for the period ending March 31, 2024. The
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX